CN106478723A - 一种噁唑烷酮类抗菌药物的晶型b及其制备方法和应用 - Google Patents
一种噁唑烷酮类抗菌药物的晶型b及其制备方法和应用 Download PDFInfo
- Publication number
- CN106478723A CN106478723A CN201610813229.6A CN201610813229A CN106478723A CN 106478723 A CN106478723 A CN 106478723A CN 201610813229 A CN201610813229 A CN 201610813229A CN 106478723 A CN106478723 A CN 106478723A
- Authority
- CN
- China
- Prior art keywords
- crystal formation
- oxazolidinone antibacterial
- antibacterial medicine
- preparation
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 60
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 239000013078 crystal Substances 0.000 title claims abstract description 52
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 230000003115 biocidal effect Effects 0.000 claims abstract description 6
- 238000002441 X-ray diffraction Methods 0.000 claims abstract description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 12
- 230000008025 crystallization Effects 0.000 claims description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000001228 spectrum Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 6
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 6
- 239000012296 anti-solvent Substances 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- 229940043265 methyl isobutyl ketone Drugs 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 238000010304 firing Methods 0.000 claims 1
- 231100000614 poison Toxicity 0.000 claims 1
- 230000007096 poisonous effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 2
- 239000007787 solid Substances 0.000 description 20
- 238000000634 powder X-ray diffraction Methods 0.000 description 12
- 230000003068 static effect Effects 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 238000000967 suction filtration Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 238000001291 vacuum drying Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 150000001875 compounds Chemical group 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000013557 residual solvent Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- ZKJGFFFHKIOTLP-AYCODJOZSA-N CC(CN(C)C(O)=O)c(cc1)ncc1-c(cc1OC[C@H]2[C@H](COP(O)(O)=O)O3)ccc1N2C3=O Chemical compound CC(CN(C)C(O)=O)c(cc1)ncc1-c(cc1OC[C@H]2[C@H](COP(O)(O)=O)O3)ccc1N2C3=O ZKJGFFFHKIOTLP-AYCODJOZSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000002447 crystallographic data Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610813229.6A CN106478723B (zh) | 2016-09-09 | 2016-09-09 | 一种噁唑烷酮类抗菌药物的晶型b及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610813229.6A CN106478723B (zh) | 2016-09-09 | 2016-09-09 | 一种噁唑烷酮类抗菌药物的晶型b及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106478723A true CN106478723A (zh) | 2017-03-08 |
CN106478723B CN106478723B (zh) | 2018-04-13 |
Family
ID=58273445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610813229.6A Expired - Fee Related CN106478723B (zh) | 2016-09-09 | 2016-09-09 | 一种噁唑烷酮类抗菌药物的晶型b及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106478723B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107353305A (zh) * | 2017-07-12 | 2017-11-17 | 浙江普洛得邦制药有限公司 | 一种噁唑烷酮类抗菌药物的三羟甲基氨基甲烷盐及其晶型a、制备方法和应用 |
CN107739391A (zh) * | 2017-11-16 | 2018-02-27 | 浙江普洛得邦制药有限公司 | 噁唑烷酮药物单脱苄基杂质及其制备方法和应用 |
CN110128473A (zh) * | 2019-06-21 | 2019-08-16 | 碧豫药业有限责任公司 | 一种噁唑烷酮类抗菌药物游离酸的晶型ⅲ及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1749256A (zh) * | 2004-09-16 | 2006-03-22 | 中国科学院上海药物研究所 | 一类新的噁唑烷酮衍生物、其制备方法和用途 |
CN102260277A (zh) * | 2010-05-24 | 2011-11-30 | 中国科学院上海药物研究所 | 新型苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
CN103896963A (zh) * | 2012-12-26 | 2014-07-02 | 中国科学院上海药物研究所 | 苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
CN106083837A (zh) * | 2016-05-27 | 2016-11-09 | 浙江普洛得邦制药有限公司 | 一种噁唑烷酮类抗菌药物及其中间体的制备方法 |
-
2016
- 2016-09-09 CN CN201610813229.6A patent/CN106478723B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1749256A (zh) * | 2004-09-16 | 2006-03-22 | 中国科学院上海药物研究所 | 一类新的噁唑烷酮衍生物、其制备方法和用途 |
CN102260277A (zh) * | 2010-05-24 | 2011-11-30 | 中国科学院上海药物研究所 | 新型苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
CN103896963A (zh) * | 2012-12-26 | 2014-07-02 | 中国科学院上海药物研究所 | 苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
CN106083837A (zh) * | 2016-05-27 | 2016-11-09 | 浙江普洛得邦制药有限公司 | 一种噁唑烷酮类抗菌药物及其中间体的制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107353305A (zh) * | 2017-07-12 | 2017-11-17 | 浙江普洛得邦制药有限公司 | 一种噁唑烷酮类抗菌药物的三羟甲基氨基甲烷盐及其晶型a、制备方法和应用 |
CN107739391A (zh) * | 2017-11-16 | 2018-02-27 | 浙江普洛得邦制药有限公司 | 噁唑烷酮药物单脱苄基杂质及其制备方法和应用 |
CN110128473A (zh) * | 2019-06-21 | 2019-08-16 | 碧豫药业有限责任公司 | 一种噁唑烷酮类抗菌药物游离酸的晶型ⅲ及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106478723B (zh) | 2018-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1914212B (zh) | Gabaa激动剂的多晶型 | |
CN101891738B (zh) | 达沙替尼多晶型物及其制备方法和药用组合物 | |
CN103930419A (zh) | 阿齐沙坦的晶型及其制备方法 | |
CN104788438B (zh) | 恩格列净b晶型及其制备 | |
CN106478723A (zh) | 一种噁唑烷酮类抗菌药物的晶型b及其制备方法和应用 | |
CN106008529A (zh) | 一种依鲁替尼溶剂化物及其制备方法 | |
CN106632481B (zh) | 一种噁唑烷酮类抗菌药物的晶型a及其制备方法和应用 | |
CN106478724B (zh) | 一种噁唑烷酮类抗菌药物的晶型c及其制备方法和应用 | |
CN106866666B (zh) | 一种帕博西尼晶型化合物及其制备方法 | |
CN102887829B (zh) | 芬戈莫德粘酸盐及其晶体的制备方法和用途 | |
CN102942577B (zh) | 一种含有头孢西丁钠化合物的药物组合物 | |
CN104892584B (zh) | 一种阿法替尼双马来酸盐无定型态及其制备方法、制剂 | |
CN105949241A (zh) | 一种噁唑烷酮类抗菌药物钠盐的晶型a及其制备方法和应用 | |
CN108948119B (zh) | 黄夹次甙乙多晶型的晶型特征、制备方法及在抗癌上的应用 | |
CN104447689B (zh) | 来那度胺的晶型及其制备方法 | |
CN108191759A (zh) | 一种格列喹酮晶体、其制备方法及含有此晶体的药物 | |
CN111606816A (zh) | 一种地佐辛晶型及其制备方法 | |
CN105461618B (zh) | 甲磺酸洛美他派新晶型及其制备方法 | |
CN105523994B (zh) | 甲磺酸洛美他派晶型iii | |
CN106496272B (zh) | 一种噁唑烷酮类抗菌药物镁盐的晶型a及其制备方法和应用 | |
CN111712486A (zh) | 卡利拉嗪盐酸盐的新晶型及其制备方法及其用途 | |
CN108727417B (zh) | 多环化合物钠盐及其多晶型、制备方法及应用 | |
CN107311954B (zh) | 来氟米特晶型化合物、制备方法及其应用 | |
CN107868117B (zh) | 司坦唑醇糖精盐及其制备方法和应用 | |
CN107311993A (zh) | 一种卡格列净的晶型ii及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180726 Address after: 201203 555 Zhangjiang Road, Zhangjiang, Pudong New Area, Shanghai Patentee after: Shanghai Institute of Materia Medica, Chinese Academy of Sciences Address before: 322118 Jiangnan Road, Hengdian Industrial Zone, Dongyang, Jinhua, Zhejiang 519 Co-patentee before: YOSEMADE PHARMACEUTICAL CO., LTD. Patentee before: Zhejiang Puluo Debang Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180413 Termination date: 20180909 |
|
CF01 | Termination of patent right due to non-payment of annual fee |